Answers are grounded in this paper and cite their sources.
Highlights the potential of novel antihypertensive agents that target multiple cardiovascular risk factors simultaneously to reduce cardiovascular disease.
Coronary heart disease and cerebrovascular disease continue to be the leading causes of illness and death among adults from developed countries. Their prevalence is strongly related to the effects of many different risk factors, including high blood pressure, cigarette smoking, dyslipidaemia and diabetes. The management of cardiovascular (CV) risk factors should be viewed as an integrated strategy of intervention aimed at correcting as many of the underlying causes of CV disease as possible. Blocking the renin-angiotensin-aldosterone system with new, well-tolerated antihypertensive drugs, and blood pressure regulation by means of new drugs that also reduce plasma cholesterol levels or improve insulin resistance and glucose tolerance, could lead to a reduction of CV diseases.
No takes yet. Share an insight, caveat, or question.
Sierra et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: